GP IIb/IIIa Receptor Inhibitors in Mechanically Ventilated Patients with Cardiogenic Shock due to Myocardial Infarction in the Era of Potent P2Y12 Receptor Antagonists
<b>Objective:</b> To investigate the association between GP IIb/IIIa receptor inhibitors (GPI) and mortality and bleeding in patients with cardiogenic shock (CS) due to myocardial infarction (MI) who were mechanically ventilated on admission. <b>Methods</b>: We retrospectivel...
Main Authors: | Vojko Kanic, Gregor Kompara, David Suran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/24/7426 |
Similar Items
-
Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
by: Salma Abdeladim, et al.
Published: (2021-01-01) -
Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression
by: Carolina Saleiro, et al.
Published: (2020-11-01) -
One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock
by: Krzysztof Myrda, et al.
Published: (2021-10-01) -
Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
by: Bastiaan Zwart, et al.
Published: (2020-02-01) -
GP IIb/IIIa-Mediated Platelet Activation and Its Modulation of the Immune Response of Monocytes Against Candida albicans
by: Lin Zheng, et al.
Published: (2021-12-01)